Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis.
作者信息
Xiong Mi, Liang Xue, Wei You-Dong
机构信息
Department of Neurology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Chongqing Key Laboratory of Neurobiology, Chongqing, China.
出版信息
Br J Haematol. 2020 Jun;189(6):1050-1052. doi: 10.1111/bjh.16725. Epub 2020 May 14.
Abstract
摘要
相似文献
1
Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis.2019年冠状病毒病（COVID-19）重症患者的凝血变化：一项荟萃分析。
Br J Haematol. 2020 Jun;189(6):1050-1052. doi: 10.1111/bjh.16725. Epub 2020 May 14.
2
The association between COVID-19 and asthma: A systematic review and meta-analysis.2019冠状病毒病与哮喘之间的关联：一项系统评价和荟萃分析。
Clin Exp Allergy. 2020 Nov;50(11):1274-1277. doi: 10.1111/cea.13733. Epub 2020 Sep 24.
3
COVID-19 cytokine storm: the interplay between inflammation and coagulation.新型冠状病毒肺炎细胞因子风暴：炎症与凝血之间的相互作用
Lancet Respir Med. 2020 Jun;8(6):e46-e47. doi: 10.1016/S2213-2600(20)30216-2. Epub 2020 Apr 27.
4
Fungal antigenemia in patients with severe Coronavirus disease 2019 (COVID-19): The facts and challenges.2019年冠状病毒病（COVID-19）重症患者的真菌血症：事实与挑战
J Microbiol Immunol Infect. 2020 Aug;53(4):657-659. doi: 10.1016/j.jmii.2020.05.010. Epub 2020 May 25.
5
Management of COVID-19-related paediatric blood samples in a clinical haematology laboratory.临床血液学实验室中与新冠病毒病相关的儿科血液样本管理
Br J Haematol. 2020 Jun;189(5):848-851. doi: 10.1111/bjh.16721. Epub 2020 May 9.
6
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and Transfusion Medicine: reflections from Italy.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）大流行与输血医学：来自意大利的思考
Blood Transfus. 2020 Mar;18(2):77-78. doi: 10.2450/2020.0071-20.
7
Haemostasis in Times of COVID-19.新冠疫情时期的止血
Hamostaseologie. 2020 May;40(2):141. doi: 10.1055/a-1081-6832. Epub 2020 May 28.
8
Cobrotoxin could be an effective therapeutic for COVID-19.眼镜蛇毒素可能是治疗新冠肺炎的一种有效疗法。
Acta Pharmacol Sin. 2020 Sep;41(9):1258-1260. doi: 10.1038/s41401-020-00501-7. Epub 2020 Aug 25.
9
The Effect of Anticoagulation Use on Mortality in COVID-19 Infection.抗凝治疗对新冠病毒感染患者死亡率的影响。
Am J Cardiol. 2020 Nov 1;134:155-157. doi: 10.1016/j.amjcard.2020.08.005. Epub 2020 Aug 15.
10
Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.2019年冠状病毒病（COVID-19）重症患者的降钙素原：一项荟萃分析。
Clin Chim Acta. 2020 Jun;505:190-191. doi: 10.1016/j.cca.2020.03.004. Epub 2020 Mar 4.
引用本文的文献
1
Evaluation of D-Dimer, P-Selectin, and miR-17-5p Expression in ICU and Non-ICU COVID-19 Patients: A Cross-sectional Study.ICU和非ICU新冠肺炎患者中D-二聚体、P-选择素和miR-17-5p表达的评估：一项横断面研究
Biochem Genet. 2025 Mar 18. doi: 10.1007/s10528-025-11062-x.
2
Genetic and Epigenetic Intersections in COVID-19-Associated Cardiovascular Disease: Emerging Insights and Future Directions.新冠病毒相关心血管疾病中的遗传与表观遗传交叉点：新见解与未来方向
Biomedicines. 2025 Feb 16;13(2):485. doi: 10.3390/biomedicines13020485.
3
The role of NOS3-rs1799983 and NOS3- rs2070744 SNP in occurrence of avascular necrosis as a post COVID-19 complication.NOS3-rs1799983 和 NOS3-rs2070744 SNP 在 COVID-19 后并发症之一的缺血性坏死发病中的作用。
BMC Med Genomics. 2024 Aug 21;17(1):217. doi: 10.1186/s12920-024-01928-1.
4
Hematological and Biochemical Laboratory Parameters in COVID-19 Patients: A Retrospective Modeling Study of Severity and Mortality Predictors.新型冠状病毒肺炎患者的血液学和生化实验室参数：严重程度和死亡率预测因子的回顾性建模研究。
Biomed Res Int. 2023 Nov 18;2023:7753631. doi: 10.1155/2023/7753631. eCollection 2023.
5
Our Experience with SARS-CoV-2 Infection and Acute Kidney Injury: Results from a Single-Center Retrospective Observational Study.我们对新型冠状病毒2型感染与急性肾损伤的经验：一项单中心回顾性观察研究的结果
Healthcare (Basel). 2023 Aug 26;11(17):2402. doi: 10.3390/healthcare11172402.
6
Investigation of Pulmonary Artery and Ascending Aorta Morphology in the Coronavirus Disease 2019: A Radioanatomical Study.2019冠状病毒病中肺动脉和升主动脉形态学研究：一项放射解剖学研究
Thorac Res Pract. 2023 Jan;24(1):40-44. doi: 10.5152/ThoracResPract.2023.22107.
7
Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence.新型冠状病毒肺炎与凝血障碍的相互关系：病理生理学和临床证据。
Int J Mol Sci. 2023 May 18;24(10):8945. doi: 10.3390/ijms24108945.
8
The Role of Computed Tomography in the Management of Hospitalized Patients With COVID-19.计算机断层扫描在新型冠状病毒肺炎住院患者管理中的作用
Cureus. 2023 Mar 28;15(3):e36821. doi: 10.7759/cureus.36821. eCollection 2023 Mar.
9
COVID-19-induced coagulopathy: Experience, achievements, prospects.COVID-19 诱导的凝血病：经验、成就、展望。
Cardiol J. 2023;30(3):453-461. doi: 10.5603/CJ.a2022.0123. Epub 2023 Jan 2.
10
Lupus anticoagulants as a prospective independent predictor in COVID-19 patients.狼疮抗凝物作为 COVID-19 患者的前瞻性独立预测因子。
Int J Lab Hematol. 2023 Apr;45(2):163-169. doi: 10.1111/ijlh.14003. Epub 2022 Dec 10.
本文引用的文献
1
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.中国武汉住院的 2019 年冠状病毒病患者的神经系统表现。
JAMA Neurol. 2020 Jun 1;77(6):683-690. doi: 10.1001/jamaneurol.2020.1127.
2
Clinical features and treatment of COVID-19 patients in northeast Chongqing.重庆东北部地区 COVID-19 患者的临床特征和治疗方法。
J Med Virol. 2020 Jul;92(7):797-806. doi: 10.1002/jmv.25783. Epub 2020 Apr 1.
3
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.SARS-CoV-2 感染患者凝血功能的显著变化。
Clin Chem Lab Med. 2020 Jun 25;58(7):1116-1120. doi: 10.1515/cclm-2020-0188.
4
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.中国武汉 2019 年冠状病毒病肺炎患者急性呼吸窘迫综合征和死亡的相关危险因素。
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.
5
[Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV].112例2019新型冠状病毒感染心血管疾病患者的临床特征与结局
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Jun 24;48(6):450-455. doi: 10.3760/cma.j.cn112148-20200220-00105.
6
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.中国武汉 140 名 SARS-CoV-2 感染患者的临床特征。
Allergy. 2020 Jul;75(7):1730-1741. doi: 10.1111/all.14238. Epub 2020 Feb 27.
7
[Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia].30例新型冠状病毒肺炎感染医护人员的临床特征
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 17;43(0):E016. doi: 10.3760/cma.j.issn.1001-0939.2020.0016.
8
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
9
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
10
Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis.纤溶酶原通过纤维蛋白溶解来控制流感病毒感染的炎症和发病机制。
PLoS Pathog. 2013 Mar;9(3):e1003229. doi: 10.1371/journal.ppat.1003229. Epub 2013 Mar 21.
Zotero 插件